Adaptive Biotechnologies (ADPT) Debt Ratio (2022 - 2026)

Adaptive Biotechnologies has disclosed Debt Ratio across 5 years of filings, most recently posting 0.26 for Q1 2026.

• In Q1 2026, Debt Ratio fell 1.3% year-over-year to 0.26; the TTM figure through Mar 2026 stood at 0.26 (down 1.3% YoY), while the FY2025 annual figure was 0.26, up 3.56% from the prior year.
• Debt Ratio came in at 0.26 for Q1 2026 at Adaptive Biotechnologies, up from 0.26 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.27 in Q2 2025 to a low of 0.15 in Q4 2022.
• Average Debt Ratio over 5 years is 0.23, with a median of 0.24 recorded in 2024.
• Year-over-year, Debt Ratio surged 35.05% in 2023 and retreated 1.3% in 2026.
• Over 5 years, Debt Ratio stood at 0.15 in 2022, then surged by 35.05% to 0.2 in 2023, then climbed by 25.03% to 0.25 in 2024, then advanced by 3.56% to 0.26 in 2025, then climbed by 0.84% to 0.26 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.26 in Q1 2026, 0.26 in Q4 2025, and 0.27 in Q3 2025.